Streetbeat News

Equity Actions

HUM

Seven analysts have recently updated their ratings on Humana (NYSE:HUM), with a mix of bullish and indifferent stances. The average 12-month price target is $588.29, slightly up from the previous $587.33. Analysts from firms like Oppenheimer, Argus Research, and JP Morgan have maintained or adjusted their ratings and price targets. Humana has shown strong financial performance with a revenue growth of 15.9%, a net margin of 3.15%, and an ROE of 4.93%, but it has a high debt-to-equity ratio of 0.71.

Portfolio Pulse from Benzinga Insights

January 17, 2024 | 5:00 pm

GLOB

Analysts have diverse opinions on Globant (NYSE:GLOB), with 8 reviews over the last three months ranging from bullish to bearish. The average 12-month price target for GLOB is $234.25, up 7.95% from the previous target of $217.00. Citigroup, Piper Sandler, UBS, Wedbush, Needham, and Keybanc are among the firms adjusting their ratings and price targets. Globant's financials show strong revenue growth and net margin, but below-average ROE. The company's market cap is below industry average, and it has a low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 17, 2024 | 5:00 pm

BCEL

DATS

LQR

MIMO

PHUN

TSP

U.S. stocks traded lower, with the Nasdaq Composite dropping over 100 points. Health care shares rose, while real estate shares fell. U.S. industrial production slightly increased. Airspan Networks (MIMO) surged after announcing a partnership with GCT Semiconductor. LQR House (LQR) rose after increasing its share buyback program. Atreca (BCEL) also gained. TuSimple (TSP) announced plans to delist from Nasdaq, causing a drop. Phunware (PHUN) fell after announcing a direct offering. DatChat (DATS) declined after pricing a public offering. Oil and gold traded down, while silver and copper also fell.

Portfolio Pulse from Avi Kapoor

January 17, 2024 | 4:44 pm

FROG

In the past three months, 6 analysts have updated their ratings on JFrog (NASDAQ:FROG), with a positive shift in sentiment. The average 12-month price target is now $37.17, up 13.22% from the previous $32.83. Analysts from firms including Needham, Truist Securities, Oppenheimer, Morgan Stanley, and Piper Sandler have adjusted their ratings and price targets, reflecting changes in market conditions and company performance. JFrog's financials show a solid revenue growth rate of 23.12% as of September 30, 2023, but it has a below-average net margin and ROE, indicating potential profitability and efficiency challenges.

Portfolio Pulse from Benzinga Insights

January 17, 2024 | 4:01 pm

DLTR

The article compares Dollar Tree (NASDAQ:DLTR) to its competitors in the Consumer Staples Distribution & Retail industry, analyzing financial metrics such as P/E, P/B, P/S, ROE, EBITDA, gross profit, revenue growth, and debt-to-equity ratio. Dollar Tree's P/E ratio is above the industry average, suggesting overvaluation, while its P/B ratio is below, indicating potential undervaluation. The company's P/S ratio is high, ROE is low, and revenue growth is below the industry average, signaling potential underperformance.

Portfolio Pulse from Benzinga Insights

January 17, 2024 | 4:00 pm

CASY

Casey's General Stores (NASDAQ:CASY) received mixed analyst ratings over the last quarter, with 4 analysts offering varied opinions. The average 12-month price target for CASY is $309.5, reflecting a 3.86% increase from the previous target of $298.00. Analysts from Benchmark, Stephens & Co., RBC Capital, and BMO Capital have provided ratings and adjusted price targets, with the highest target set at $340.00 by Stephens & Co. Casey's operates over 2,500 convenience stores and has shown solid revenue growth, strong net margin, and excellent ROE and ROA, indicating good financial health and efficient management. The company's market capitalization is above industry averages, and it has a lower than average debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 17, 2024 | 4:00 pm

CABO

CHTR

CMCSA

Charter Communications (NASDAQ:CHTR) is analyzed against industry competitors, showing a low PE ratio, high PB ratio, low PS ratio, high ROE, EBITDA, and revenue growth, but lower gross profit and a high debt-to-equity ratio. These factors suggest CHTR may be undervalued with strong profitability and growth potential, but also indicate potential financial risk due to high debt levels.

Portfolio Pulse from Benzinga Insights

January 17, 2024 | 4:00 pm

CDW

CDW Corp (NASDAQ:CDW) is analyzed in comparison to its competitors in the Electronic Equipment, Instruments & Components industry. CDW trades at a premium with higher P/E, P/B, and P/S ratios than the industry average. It has a higher ROE, indicating efficient profit generation, and its EBITDA and gross profit are significantly above the industry average. However, CDW's revenue growth is negative and below the industry average. The company also has a higher debt-to-equity ratio compared to its top 4 peers, suggesting increased financial risk.

Portfolio Pulse from Benzinga Insights

January 17, 2024 | 4:00 pm

CVS

CVS Health (NYSE:CVS) has experienced an 11.3% increase in short interest since the last report, with 16.45 million shares sold short, representing 1.28% of available shares. It would take about 2.42 days to cover all short positions. While an increase in short interest can indicate bearish sentiment, it does not necessarily predict a price drop. CVS Health's short interest is below its peer group average of 8.87%.

Portfolio Pulse from Benzinga Insights

January 17, 2024 | 3:45 pm

TSP

TuSimple, a self-driving truck company, has announced its intention to delist from the Nasdaq stock exchange, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 3:30 pm